EMB-02

N/A

Report date: 2024/06/11 20:00:08

Base Information

Drug NameEMB-02
Drug Alias NameEMB-02
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionLymphocyte activation gene 3 protein inhibitorsProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1Lymphocyte activation gene 3 protein
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Epimab Biotherapeutics, Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Epimab Biotherapeutics, Inc
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A